Skip Navigation

Profile

Gopal H. Badlani, M.D.Wake Forest Baptist Health

Doctor Rating

4.5 out of 5

231 Ratings
16 Comments
 

Gopal H. Badlani, M.D.

Professor,


Clinical Interests

Incontinence, Urology, Reconstructive Urology

Contact Information

Returning Patient Appointments: 336-716-4131
Department: 336-716-4131

Insurance Accepted »

Media Medical Expert »

Education & Training

  • M.D., Bombay Univ Topiwala Medical College-India, 1972

Board Certifications

  • American Board of Urology, Female Pelvic Medicine and Reconstructive Surgery

Memberships

  • Nat'L Kidney Foundation
  • Am Coll Of Surgeons
  • American Urological Assn

NPI Number

  • 1811930365
Gopal H. Badlani, M.D.

Doctor Rating

4.5 out of 5

231 Ratings
16 Comments
 

Gopal H. Badlani, M.D.

Professor, Urology
Office of Women in Medicine and Science
Institute for Regenerative Medicine

Research Interests

Surgical Mesh; Urinary Incontinence, Stress; Pelvic Organ Prolapse; Prostatic Hyperplasia; Biocompatible Materials
More »

Contact Information

Academic: 336-716-5928 | Department: 336-716-4131

Media Medical Expert »

Recent Publications

Evaluation of the efficacy of postmortem human bladder tissue as a normal comparator for case-controlled gene expression studies in urology. Matthews CA, Eschenroeder A, Badlani G, Evans R, Walker SJ.. Neurourol Urodyn. 2017;36(4):1076-1080.

Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiency. Williams JK, Dean A, Lankford S, Criswell T, Badlani G, Andersson KE.. Stem Cell Res Ther. 2017;8(1):1.

Bladder capacity is a biomarker for a bladder-centric versus systemic manifestation in interstitial cystitis/bladder pain syndrome. Walker SJ, Zambon J, Andersson KE, Langefeld C, Matthews CA, Badlani G, Bowman H, Evans RJ.. J Urol. 2017;198(2):369-374.

Transvaginal mesh increases the risk of bleeding, organ surgical site infection, and pulmonary embolism in vaginal pelvic reconstruction surgery: results from a multi-institutional dataset [abstract]. Caveney MK, Haddad D, Matthews CA, Badlani GH, Mirzazadeh M.. Neurourol Urodyn. 2017;36(Suppl 1):S110.

Short-term complications associated with the use of transvaginal mesh in pelvic floor reconstructive surgery: results from a multi-institutional prospectively maintained dataset. Caveney M, Haddad D, Matthews C, Badlani G, Mirzazadeh M.. Neurourol Urodyn. 2017;():.

Urinary neurotrophin levels increase in women with stress urinary incontinence after a midurethral sling procedure [editorial comment]. Badlani G.. Urology. 2017;99():54-55.

International volunteerism and global responsibility. Badlani G.. Transl Androl Urol. 2017;6(2):258-263.

Comparison of surgical outcomes in benign prostatic hypertrophy management using the National Surgical Quality Improvement Program [abstract]. Haddad D, Krane L, Badlani G, Mirzazadeh M.. Neurourol Urodyn. 2016;35(Suppl 1):S37.

Trends in mesh usage and resident involvement for vaginal surgery from the National Surgical Quality Improvement Program [abstract]. Haddad D, Krane L, Mirzazadeh M, Badlani G.. Neurourol Urodyn. 2016;35(Suppl 1):S81.

Do we need new patient reported measures to evaluate lower urinary tract dysfunction? [editorial]. Keys TR, Kirkali Z, Badlani G.. Indian J Urol. 2016;32(2):91-92.

Cell versus chemokine therapy in a nonhuman primate model of chronic intrinsic urinary sphincter deficiency. Williams JK, Dean A, Badra S, Lankford S, Poppante K, Badlani G, Andersson KE.. J Urol. 2016;196(6):1809-1815.

Vaginal mesh exposure presentation, evaluation, and management. Zambon JP, Badlani GH.. Curr Urol Rep. 2016;17(9):65.

Regenerative medicine therapies for stress urinary incontinence. Williams JK, Dean A, Badlani G, Andersson KE.. J Urol. 2016;196(6):1619-1626.

Predictors of recurrence and successful treatment following obstetric fistula surgery [editorial comment]. Badlani GH.. Urology. 2016;97():84-85.

Local versus intravenous injections of skeletal muscle precursor cells in nonhuman primates with acute or chronic intrinsic urinary sphincter deficiency. Williams JK, Badlani G, Dean A, Lankford S, Poppante K, Criswell T, Andersson KE.. Stem Cell Res Ther. 2016;7(1):147.

Urinary tract fistulae. Badlani GH, De Ridder DJMK, Mettu JR, Rovner ES. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA, eds. Campbell-Walsh urology. 11th ed. Philadelphia (PA): Elsevier;2016: 2103-39.e9.

Complications of transvaginal mesh for pelvic organ prolapse and stress urinary incontinence: tips for prevention, recognition, and management. MacDonald S, Terlecki R, Costantini E, Badlani G.. Eur Urol Focus. 2016;2(3):260-267.

The scientific basis for the use of biomaterials in stress urinary incontinence (SUI) and pelvic organ prolapse (POP). Colaco M, Mettu J, Badlani G.. BJU Int. 2015;115(6):859-866.

Evaluation of patients' perceptions of mesh usage in female pelvic medicine and reconstructive surgery [editorial comment]. Badlani GH.. Urology. 2015;85(2):331-332.

Transvaginal mesh increases the risk of bleeding and organ surgical site infection in vaginal pelvic reconstruction [abstract]. Haddad D, Krane L, Badlani G, Mirzazadeh M.. Neurourol Urodyn. 2015;34(Suppl 3):S354-S355.

Clinical Research Office of the Endourological Society Global GreenLight Laser Study: outcomes from a contemporary series of 713 patients. de la Rosette J, Elhilali M, Naito S, Unal D, Razvi H, Liatsikos E, Bachmann A, Tubaro A, Alivizatos G, Mak SK, Badlani G, Eltahawy E, Wong C, Telich Vidal M, Te A, d'Ancona F, Arum CJ, Gutierrez J.. Int J Urol. 2015;22(12):1124-1130.

The management of prostatic obstruction with urethral stents. Peyton CC, Badlani GH.. Can J Urol. 2015;22(5 Suppl 1):75-81.

Dedicated research time in urology residency: current status. Peyton CC, Badlani GH.. Urology. 2014;83(4):719-725.

Reply [to editorial comment on 'Dedicated research time in urology residency: current status'] [letter]. Peyton CC, Badlani GH.. Urology. 2014;83(4):725.

The medicolegal and economic implications of FDA communications regarding the use of transvaginal mesh [abstract]. Colaco M, Hester A, Sandberg J, Mettu J, Badlani G.. Neurourol Urodyn. 2014;33(2):240-241.

. Badlani G, ed.. In: Minimally invasive therapy for urinary incontinence and pelvic organ prolapse. New York: Springer;2014: .

Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome. Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson KE, Walker SJ.. J Urol. 2014;192(4):1123-1129.

Foreward. Badlani G, Agarwal MM.. Manual of Urodynamics. 2014;():.

Evidence-based outcomes for mesh-based surgery for pelvic organ prolapse. Mettu JR, Colaco M, Badlani GH.. Curr Opin Urol. 2014;24(4):370-374.

Editorial: advances in female urology. Badlani GH.. Curr Opin Urol. 2014;24(4):329.

Patient perception of transvaginal mesh and the media [editorial comment]. Badlani GH.. Urology. 2014;84(3):581-582.

Pelvic organ prolapsed in women: is training beneficial? [editorial]. Colaco M, Badlani G.. Natl Med J India. 2014;27(2):86-87.

Transcriptome analysis of bladder biopsy from interstitial cystitis/bladder pain syndrome patients. Walker SJ, Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson KE.. Genom Data. 2014;2():366-368.

Transvaginal mesh kits--how 'serious' are the complications and are they reversible? [editorial comment]. Badlani G.. Urology. 2013;81(1):48-49.

Re: post-implantation alterations of polypropylene in the human [letter]. Keys T, Aboushwareb T, Badlani G.. J Urol. 2013;189(5):1996-1997.

Influencing factors leading to malpractice litigation in radical prostatectomy. Colaco M, Sandberg J, Badlani G.. J Urol. 2013;191(6):1770-1775.

Evidence-based medicine for polypropylene mesh use compared with native tissue vaginal prolapse repair [editorial comment]. Badlani GH.. Urology. 2012;79(1):14.

Enhanced MMP-1 transcription: role in the development of SUI and POP [abstract]. Keys T, Gorbachinsky I, Mckenzie P, Campeau L, Rohozinski J, Andersson K-E, Langefeld C, Badlani G.. Neurourol Urodyn. 2012;31(2):244.

. Smith AD, Preminger G, Badlani G, Kavoussi L, eds.. In: Smith's textbook of endourology. 3rd ed. Chichester, West Sussex (UK): Wiley;2012: .

Equipment set-up and patient handouts. Agarwal MM, Combs CR, Badlani GH. In: Smith AD, Preminger G, Badlani G, Kavoussi L, eds. Smith's textbook of endourology, vol 2. 3rd ed. Chichester, West Sussex (UK): Wiley;2012: 1468-1480.

Bipolar vaporization of the prostate. Richards KA, Badlani GH. In: Smith AD, Preminger G, Badlani G, Kavoussi L, eds. Smith's textbook of endourology, vol 2. 3rd ed. Chichester, West Sussex (UK): Wiley-Blackwell;2012: 1610-1616.

Maxi/pubovaginal sling. Smith AD, Preminger G, Badlani G, Kavoussi L, eds.. In: Smith's textbook of endourology, vol 2. 3rd ed. Chichester, West Sussex: Wiley-Blackwell;2012: 1699-1705.

Synthetic mesh in the surgical repair of pelvic organ prolapse: current status and future directions. Keys T, Campeau L, Badlani G.. Urology. 2012;80(2):237-243.

Minimum 1.5-year results of 'surgeon-tailored' transvaginal mesh repair for female stress urinary incontinence and pelvic organ prolapse [editorial comment]. Badlani GH.. Urology. 2012;80(2):279.

Mesh complications in female pelvic floor reconstructive surgery and their management: a systematic review. Shah HN, Badlani GH.. Indian J Urol. 2012;28(2):129-153.

The incidence and etiology of overactive bladder in patients after cerebrovascular accident. McKenzie P, Badlani GH.. Curr Urol Rep. 2012;13(5):402-406.

Farewell [editorial]. Badlani GH.. J Endourol. 2011;25(1):7.

Comparison of MMP-1 enzymatic activity and TIMP-1 inhibition in women with pelvic organ prolapse [abstract]. Campeau L, Gorbachinsky I, Ziegler JT, Langefeld CD, Andersson KE, Rohozinski J, Badlani G.. Neurourol Urodyn. 2011;30(2):240-241.

Stress urinary incontinence in women: diagnosis and treatment based on the evaluation AUA guidelines [Czech]. Gorgachinsky I, Badlani GH.. List Urol [Czech]. 2011;9(1):38-43.

Is tissue engineering and biomaterials the future for lower urinary tract dysfunction (LUTD)/pelvic organ prolapse (POP)?. Aboushwareb T, Mckenzie P, Wezel F, Southgate J, Badlani G.. Neurourol Urodyn. 2011;30(5):775-782.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Urology

Clinical Interests

Incontinence, Urology, Reconstructive Urology
Gopal H. Badlani, M.D.

Gopal H. Badlani, M.D.

Professor, Urology
Office of Women in Medicine and Science
Institute for Regenerative Medicine

Doctor Rating

4.5 out of 5

Gopal H. Badlani, M.D.231 Ratings
16 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.5
CP efforts to include in decisions
4.5
CP explanations of prob/condition
4.6
CP spoke using clear language
4.6
Friendliness/courtesy of CP
4.7
Likelihood of recommending CP
4.5
Patients' confidence in CP
4.6
Time CP spent with patient
4.4
Wait time at clinic
4.1



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

9/6/2017

the best among an excellent group of physicians

8/15/2017

*Dr. Badlani is a great doc. A little abrupt on occasion but a good man who shows moderate concern. 8. 10 minutes.

8/7/2017

he's a very nice doctor

7/25/2017

I have a lot of confidence in Dr. Badlani.

7/21/2017

*Dr. Badlani is the best! 9. EXCELLENT.

7/9/2017

*Dr. Badlani always makes me feel as though I am his ONLY patient for the day. He is never rushed.

5/27/2017

To me *Dr. Badlani is the best.

5/20/2017

*Dr. Badiani is a very nice and personal man! We love him and recommend him to others.

4/10/2017

Pleasant, careful to listen & explain my "homework," & next stage of testing and then initiate appropriate meds etc.

4/5/2017

He's very experience and knowledgeable.

3/20/2017

1) PROVIDER DID NOT CALL PRESCRIPTION INTO CORRECT PHARMACY, ALMOST A WEEK AND TWO(2) RETURN VISITS TO FINALLY GET NEEDED PRESCRIPTION FILLED. 2) WAITED TWENTY THREE (23) MINUTES TO SEE PROVIDER, WHO SAID HE WAS RUNNING LATE! 3) URINE SAMPLE RESULT EXPLANATION NOT PROVIDED TO DATE; REQUESTED BY PHONE W/ NO RESPONSE,

1/31/2017

Excellent!

1/2/2017

good

1/1/2017

Dr Badlani is an amazingly great clinician. Here's a world renown doctor who sought out my wife at work to state I urgently needed to see him because he noticed I'd been hospitalized with a severe UTI. I haven't seen him in two years, yet he's following my problems. Truly outstanding.

11/28/2016

I would recommend Dr. Bedlani. He knows what he is doing. I have all the respect for him and he is down to earth.

11/1/2016

Seemed to have simple answer to a previously clouded issue.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsMagnet Hospital RecognitionJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.